← Evidence map

ArticleBiomedicines2022

TNBC Therapeutics Based on Combination of Fusarochromanone with EGFR Inhibitors.

Natalie Carroll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36428475